Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy
- 1 November 1996
- journal article
- Published by Elsevier in Epilepsy Research
- Vol. 25 (3) , 291-297
- https://doi.org/10.1016/s0920-1211(96)00084-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Tiagabine prevents seizures, neuronal damage and memory impairment in experimental status epilepticusEuropean Journal of Pharmacology, 1996
- Vigabatrin vs Carbamazepine Monotherapy in Patients With Newly Diagnosed EpilepsyArchives of Neurology, 1995
- Effects of Differing Dosages of Vigabatrin (Sabril) on Cognitive Abilities and Quality of Life in EpilepsyEpilepsia, 1995
- Evaluation of the effects of vigabatrin on cognitive abilities and quality of life in epilepsyNeurology, 1993
- Place of Newer Antiepileptic Drugs in the Treatment of EpilepsyDrugs, 1993
- The γ-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake ratsEuropean Journal of Pharmacology, 1992
- Effects of Vigabatrin on Cognitive Function and Mood When Used as Add‐on Therapy in Patients with Intractable EpilepsyEpilepsia, 1992
- Computerized Neuropsychological Assessment of Cognitive Functioning in Children with EpilepsyEpilepsia, 1990
- GABAergic mechanisms in the pathogenesis and treatment of epilepsy.British Journal of Clinical Pharmacology, 1989
- A Practical Guide for Routine EEG Studies in EpilepsyJournal Of Clinical Neurophysiology, 1984